Condition: Gastrointestinal Microbiome (Focus) · Gastrointestinal Symptoms · Sponsor: Chr Hansen - part of Novonesis
The study is a single-center, randomized, double-blind, placebo-controlled study in middle-aged to elderly adults with excessive body weight. The study includes an 8-week intervention period followed by a 2-week follow-up period. The study will evaluate the effect of a synbiotic consisting of two probiotic strains and a prebiotic. The aim is to investigate the effect of the synbiotic on modulating the gut microbiota and improving markers of gastrointestinal permeability and integrity and gastrointestinal discomfort.
This description comes directly from the study's public registry record.
Sara Engel, PhD · +45 45 74 74 74 · saen@novonesis.com
Emma Harrington · eharrington@atlantiatrials.com
Always discuss trial participation with your own doctor first.
| Atlantia Clinical Trials Ltd | Cork, Blackpool, Ireland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07453823